Antidiabetic Effects of Methysulfonlymethane (MSM), an Organosulfur Compound, in Obese Mice with Type 2 Diabetes

被引：0
|
作者：
Lima, Ines S.
Seo, Ji A.
Gaspar, Joana M.
Lee, Seung-Hoon
Kim, Young-Bum
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1129-P
引用
收藏
页码：A294 / A294
页数：1
相关论文
共 50 条
  • [21] Antidiabetic therapy of type-2 diabetes
    Clodi, Martin
    Fasching, Peter
    Hoppichler, Friedrich
    Kautzky-Willer, Alexandra
    Lechleitner, Monika
    Ludvik, Bernhard
    Prager, Rudolf
    Roden, Michael
    Schernthaner, Guntram
    Toplak, Hermann
    Wascher, Thomas C.
    Weitgasser, Raimund
    WIENER KLINISCHE WOCHENSCHRIFT, 2009, 121 : S13 - S17
  • [22] Should Side Effects Influence the Selection of Antidiabetic Therapies in Type 2 Diabetes?
    Grunberger, George
    CURRENT DIABETES REPORTS, 2017, 17 (04)
  • [23] Antidiabetic Effects of Physical Activity: How It Helps to Control Type 2 Diabetes
    Wake, Addisu Dabi
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2020, 13 : 2909 - 2923
  • [24] Endothelial dysfunction in patients with type 2 diabetes and the effects of thiazolidinedione antidiabetic agents
    Dandona, P
    Aljada, A
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2004, 18 (02) : 91 - 102
  • [25] Should Side Effects Influence the Selection of Antidiabetic Therapies in Type 2 Diabetes?
    George Grunberger
    Current Diabetes Reports, 2017, 17
  • [26] EFFECTS OF PARABIOSIS OF OBESE WITH DIABETES AND NORMAL MICE
    COLEMAN, DL
    DIABETOLOGIA, 1973, 9 (04) : 294 - 298
  • [27] A comparative study of the antidiabetic effects exerted by live and dead multi-strain probiotics in the type 2 diabetes model of mice
    Li, Xiangfei
    Xu, Qi
    Jiang, Tian
    Fang, Shuguang
    Wang, Gang
    Zhao, Jianxin
    Zhang, Hao
    Chen, Wei
    FOOD & FUNCTION, 2016, 7 (12) : 4851 - 4860
  • [28] The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice
    Yang, ZD
    Chen, M
    Wu, R
    McDuffie, M
    Nadler, JL
    DIABETOLOGIA, 2002, 45 (09) : 1307 - 1314
  • [29] The anti-inflammatory compound lisofylline prevents Type I diabetes in non-obese diabetic mice
    Z.-D. Yang
    M. Chen
    R. Wu
    M. McDuffie
    J.-L. Nadler
    Diabetologia, 2002, 45 : 1307 - 1314
  • [30] Effects of metformin on fibrinogen levels in obese patients with type 2 diabetes
    Fanghänel, G
    Silva, U
    Sanchez-Reyes, L
    Sisson, D
    Sotres, D
    Torres, EM
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1998, 50 (05): : 389 - 394
12345